NPM1 and acute myeloid leukemia: More than 20 driver recurrent mutations were unveiled in AML patients, the most frequent of which occur in Nucleophosmin 1 (NPM1) and Fms-Like Tyrosine Kinase 3 (FLT3) [18,19,20].